Disclosures for "Indirect Comparison of Lenadogene Nolparvovec Gene Therapy versus Natural History in m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy Patients")
-
Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophoenix. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurodiem. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Chiesi/Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
-
Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici.
-
Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GenSight Biologics.
-
Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurophoenix. The institution of Dr. Biousse has received research support from NIH. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
-
Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme.
-
The institution of Prem S. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenSight Biologics. The institution of Prem S. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Prem S. Subramanian has received personal compensation in the range of $0-$499 for serving as a Consultant for Invex Therapeutics. The institution of Prem S. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Prem S. Subramanian has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-Ophthalmology Society. Prem S. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. The institution of Prem S. Subramanian has received research support from Horizon Therapeutics. The institution of Prem S. Subramanian has received research support from NIH. The institution of Prem S. Subramanian has received research support from GenSight Biologics. The institution of Prem S. Subramanian has received research support from Santhera Pharmaceuticals . Prem S. Subramanian has received intellectual property interests from a discovery or technology relating to health care. Prem S. Subramanian has received publishing royalties from a publication relating to health care.
-
Dr. Vignal-Clermont has nothing to disclose.
-
Prof. Wang has received research support from Gensight Biologics.
-
Sean Donahue has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensight.
-
Prof. LEROY has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akouos. The institution of Prof. LEROY has received research support from Novartis. The institution of Prof. LEROY has received research support from GenSight Therapeutics.
-
Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
-
Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GenSight Biologics. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi GmbH. Dr. Klopstock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GenSight Biologics.
-
Dr. Sadun has received publishing royalties from a publication relating to health care.
-
Prof. Rebolleda has nothing to disclose.
-
Dr. Chwalisz has nothing to disclose.
-
Rudrani Banik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guardion Health Sciences. Rudrani Banik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Healthy Directions. Rudrani Banik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for USAG NY. Rudrani Banik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple legal firms for IMEs. The institution of Rudrani Banik has received research support from Regenera. The institution of Rudrani Banik has received research support from Quark Pharmaceuticals.
-
Magali Taiel has nothing to disclose.
-
Jose-Alain Sahel has received stock or an ownership interest from Prophesee. Jose-Alain Sahel has received stock or an ownership interest from Pixium Vision. Jose-Alain Sahel has received stock or an ownership interest from Tilak Healthcare. The institution of Jose-Alain Sahel has received research support from LabEx LIFESENSES (ANR-10-LABX-65). The institution of Jose-Alain Sahel has received research support from IHU FOReSIGHT (ANR-18-IAHU-01). The institution of Jose-Alain Sahel has received research support from ERC Synergy "HELMHOLTZ".